{"doi":"10.1016/j.rpth.2023.100147","title":"Social determinants of health in pulmonary embolism management and outcome in hospitals: Insights from the United States nationwide inpatient sample","abstract":"Background: The role of social determinants in the treatment and course of acute pulmonary embolism (PE) is understudied. Objective: To investigate the association between social determinants of health with in-hospital management and early clinical outcomes following acute PE. Methods: We identified hospitalizations of adults with acute PE discharge diagnosis from the nationwide inpatient sample (2016-2018). Multivariable regression was used to investigate the association between race/ethnicity, type of expected primary payer, and income with the use of advanced PE therapies (thrombolysis, catheter-directed treatment, surgical embolectomy, extracorporeal membrane oxygenation), length of stay, hospitalization charges, and in-hospital death. Results: , 1.09; 95% CI, 1.02-1.17). Among high-risk PE, patients of other than the White race had the highest in-hospital mortality. Conclusion: We observed inequalities in advanced therapies used for acute PE and higher in-hospital mortality in races other than White. Low socioeconomic status was also associated with lesser use of advanced treatment modalities and greater in-hospital mortality. Future studies should further explore and consider the long-term impact of social inequities in PE management.","journal":"Research and Practice in Thrombosis and Haemostasis","year":2023,"id":322145,"datarank":1.5451044958078763,"base_score":3.7376696182833684,"endowment":3.7376696182833684,"self_citation_contribution":0.5606504427425053,"citation_network_contribution":0.9844540530653709,"self_endowment_contribution":0.5606504427425053,"citer_contribution":0.9844540530653709,"corpus_percentile":86.56300765838942,"corpus_rank":1738,"citation_count":41,"citer_count":32,"citers_with_citation_signal":22,"citers_with_endowment":22,"datacite_reuse_total":0,"is_dataset":true,"is_dataset_confidence":0.5938,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2023-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1035528,"name":"Luca Valerio","orcid":"0000-0003-4466-0724","position":1,"is_corresponding":false},{"id":632475,"name":"George Giannakoulas","orcid":"0000-0001-7491-6319","position":2,"is_corresponding":false},{"id":1035529,"name":"Lukas Hobohm","orcid":"0000-0002-4312-0366","position":3,"is_corresponding":false},{"id":51219,"name":"Mary Cushman","orcid":"0000-0002-7871-6143","position":4,"is_corresponding":false},{"id":104085,"name":"Gregory Piazza","orcid":"0000-0003-1407-5276","position":5,"is_corresponding":false},{"id":104089,"name":"Stavros Konstantinides","orcid":"0000-0001-6359-7279","position":6,"is_corresponding":false},{"id":842490,"name":"Stefano Barco","orcid":"0000-0002-2618-347X","position":7,"is_corresponding":false},{"id":1035527,"name":"Ioannis T. Farmakis","orcid":"0000-0002-0586-6386","position":0,"is_corresponding":true}],"reference_count":28,"raw_metadata":null,"created_at":"2026-07-19T01:07:42.497873Z","pmid":"37181280","pmcid":"PMC10173008","fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}